Quick Takeaways
- Murchinson Ltd. filed SCHEDULE 13G for Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share (PTHS).
- Disclosed ownership: 9.1%.
- Date of event: 30 Sep 2025.
Murchinson Ltd. - 30 Sep 2025 SCHEDULE 13G Report for Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share (PTHS)
- Filing Manager
- Murchinson Ltd.
- Reporting Manager
- Murchinson Ltd.
- Symbol
- PTHS
- Shares outstanding
- 3,076,923 shares
- Disclosed Ownership
- 280,000 shares
- Ownership
- 9.1%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Nov 2025, 13:52:26 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Murchinson Ltd. disclosed 9.1% ownership in Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share (PTHS) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 13:52.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Murchinson Ltd. | 9.1% | 280,000 | 0 | 280,000 | /s/ Marc Bistricer | Marc Bistricer, Chief Executive Officer | |
| Marc Bistricer | 9.1% | 280,000 | 0 | 280,000 | /s/ Marc Bistricer | Marc Bistricer, Individually |